JIPMER PhD Admission 2026 notification has been officially released for NET-qualified candidates seeking admission to the PhD Programme at Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry. JIPMER is an Institution of National Importance under the Ministry of Health & Family Welfare, Government of India.
The institute invites applications for the February 2026 PhD session across multiple biomedical, clinical and public health research disciplines. Candidates must apply in the prescribed format and select research topics from approved projects.
See Ongoing PhD Admission- About JIPMER
- PhD Streams
- Important Dates
- Approved PhD Subjects
- Eligibility
- Application Fees
- Selection Process
- Admission Fees
- Accommodation
- PhD Duration
- Contact Details
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry has been functioning under the Government of India since 1956 and was declared an Institution of National Importance through the JIPMER Act, 2008. The institute provides undergraduate, postgraduate, super-specialty and doctoral research programs through advanced clinical and research facilities.
| Stream | Description |
|---|---|
| NET PhD | UGC/CSIR/ICMR/DBT fellowship holders selected through interview |
| Project PhD | Admission through externally funded projects |
| Institute PhD | Intramural funded PhD positions |
| ICMR-DHR PhD | Part-time PhD for in-service candidates |
| Event | Date |
|---|---|
| Application Start | 25 February 2026 |
| Soft Copy Submission Last Date | 10 March 2026 |
| Hard Copy Submission Last Date | 15 March 2026 |
| Eligible Candidates List | 25 March 2026 |
| Interview | Will be notified |
| Final Result (Tentative) | 30 April 2026 |
Applicants can select a maximum of three research topics from the following approved PhD projects.
| Sl No | Department | PhD Topic |
|---|---|---|
| 1 | Biochemistry | Synaptic plasticity gene expression in schizophrenia |
| 2 | Biochemistry | Cardiovascular complication prediction in CKD |
| 3 | Biochemistry | Steroid responsiveness prediction in nephrotic syndrome |
| 4 | Biochemistry | Methotrexate response prediction in psoriasis |
| 5 | Biochemistry | HSP70 expression in gestational diabetes |
| 6 | Biostatistics | Quality of life modelling in chronic diseases |
| 7 | Clinical Immunology | Immunogenetic signatures in axial spondyloarthritis |
| 8 | Clinical Immunology | Immune cell signatures in lupus |
| 9 | Clinical Pharmacology | Lithium response genes in bipolar disorder |
| 10 | Clinical Pharmacology | Curcumin therapy in lymphoma |
| 11 | Dermatology | Therapeutic targets for lichen planus pigmentosus |
| 12 | Dermatology | ML prediction of steroid-induced hyperglycemia |
| 13 | Emergency Medicine | Resuscitation workflow tracking technology |
| 14 | Emergency Medicine | Simulation-based emergency safety analysis |
| 15 | Endocrinology | HRT effects on metabolic liver disease |
| 16 | Endocrinology | Epigenetic signatures in gestational diabetes |
| 17 | Medical Oncology | Drug metabolism targeting chemotherapy resistance |
| 18 | Medical Oncology | Psychological prehabilitation in lung cancer |
| 19 | Medical Oncology | Methylation microbiome interaction in gastric cancer |
| 20 | Microbiology | Mucorales antifungal susceptibility study |
| 21 | Microbiology | RSV genomic determinants research |
| 22 | Obstetrics & Gynecology | Midwife-led intrapartum care research |
| 23 | Obstetrics & Gynecology | Molecular characterization in placenta previa |
| 24 | Obstetrics & Gynecology | Early gestational diabetes treatment outcomes |
| 25 | Obstetrics & Gynecology | Preeclampsia prediction model |
| 26 | Obstetrics & Gynecology | Heparin pharmacokinetics in pregnancy |
| 27 | Otorhinolaryngology | Speech envelope neural encoding in infancy |
| 28 | Pathology | Mutation landscape in breast & ovarian cancer |
| 29 | Physiology | Yoga module effects in depression |
| 30 | Physiology | Yoga therapy in diabetic cardiomyopathy |
| 31 | Physiology | Probiotic supplementation cardiovascular study |
| 32 | Preventive & Social Medicine | Technology solutions for learning disabilities |
| 33 | Preventive & Social Medicine | Digital postnatal exercise evaluation |
| 34 | Preventive & Social Medicine | NGO involvement in national health programs |
| 35 | Preventive & Social Medicine | Elderly neglect assessment validation |
| 36 | Preventive & Social Medicine | Tuberculosis in pregnancy outcomes |
| 37 | Preventive & Social Medicine | Environmental heat stress interventions |
| 38 | Psychiatry | Medication adherence tool development |
| 39 | Psychiatry | Maternal depression & infant development |
| 40 | Transfusion Medicine | Prediction tool for vasovagal reactions |
- Medical Qualification: MBBS/MD/MS/DM/MCh/DNB
- Non-Medical Qualification: Master’s degree from UGC recognised university
- Nursing Qualification: M.Sc Nursing
- Minimum 50% aggregate marks required
- Distance learning master’s degree not eligible
- JRF/SRF or equivalent fellowship mandatory
| Category | Fee |
|---|---|
| General/EWS | ₹1,500 |
| OBC | ₹1,500 |
| SC/ST | ₹1,200 |
| PwD | Exempted |
- Application Screening
- Viva-Voce Interview
- Rank list based on interview marks
- Minimum 50% marks required
- Topic allotment based on rank & preference
| Fee Component | Amount |
|---|---|
| Admission Fee | ₹3,000 |
| Caution Deposit | ₹3,000 |
| Tuition Fee | ₹2,200 |
| Learning Resource Fee | ₹6,000 |
| Student Info Fee | ₹1,500 |
| ID Card | ₹150 |
| Total at Admission | ₹15,850 |
| Annual Fee (From 2nd Year) | ₹9,700 |
In-campus accommodation is limited and not guaranteed. Scholars may arrange accommodation outside campus.
- Minimum Duration: 3 Years
- Maximum Duration: 5 Years (Full-Time)
- Part-Time Maximum: 6 Years
- 30 days leave allowed annually
- Break of study not permitted
Dean (Research), JIPMER
Dhanvantri Nagar, Puducherry – 605006
- Phone: 0413-2298288
- Email: research@jipmer.edu.in
- Website: www.jipmer.edu.in
